Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

A Commentary On Biopharma’s Current Boston Fixation
A Commentary On Biopharma’s Current Boston Fixation Merck recently announced its plans to lay off R&D workers at three East Coast sites; a move that will supposedly affect less than 10 percent of discovery, preclinical, and early development employees in Kenilworth and Rahway, N.J., and North Wales, PA.  Continue Reading...
Is BIO’s Annual Meeting Too Big?
Is BIO’s Annual Meeting Too Big? As a past BIO educational planning committee co-chair, I am well aware of the amount of effort that goes into the successful planning one of our industry’s biggest gatherings — BIO International’s Annual Convention. Typically drawing more than 15,000 attendees from nearly every U.S. state and over 65 countries, this year’s event took place June 6 – 9 at the Moscone Center in San Francisco. And while I have always...  Continue Reading...
Who Will Move Biopharma Beyond The Cutting Edge At BIO 2016?
Who Will Move Biopharma Beyond The Cutting Edge At BIO 2016? When you think of companies that revolutionized the way business is done, it is important to consider the attributes of their founders. Often they had gained life experience from working in businesses best be described as tangential to those they eventually disrupted. As a result, these “outsiders” not only brought a different perspective toward tackling problems in these industries, their wisdom to do things differently than in the...  Continue Reading...
How HBA’s Woman Of The Year Became A Successful Leader
How HBA’s Woman Of The Year Became A Successful Leader As Jennifer Cook strides across the stage at the Hilton New York Midtown, it is difficult to envision the 2016 Healthcare Businesswomen’s Association’s (HBA) Woman of the Year (WOTY) as being anything but extremely confident. But during her acceptance speech, the Roche executive paints a very different portrait of her early self. “When I was growing up, I was shy, very studious, and quite frankly, insecure,” she admits.  Continue Reading...
Are You Ready For HBA WOTY 2016?
Are You Ready For HBA WOTY 2016? On Thursday, May 12, the Healthcare Businesswomen’s Association (HBA) will host its 27th annual Woman of the Year (WOTY) at the Hilton New York Midtown. The celebration draws over 2,000 women and men from throughout the healthcare industry and showcases the HBA’s core purpose of furthering the advancement and impact of women in the business of healthcare. For those who have never attended, the ceremony involves much more than the...  Continue Reading...
Your BIO Convention 2016 Planning Guide
Your BIO Convention 2016 Planning Guide Having begun my preparations for the upcoming BIO 2016 International Convention, June 6 – 9 at the Moscone Center in San Francisco, I thought I would share some insights to help with your planning. First, in case you weren’t aware, the Moscone Center consists of three separate buildings: Moscone Center West, North, and South (see map here). While this might not seem like a big deal, if you plan on attending some of the educational...  Continue Reading...
Tackling Rising Healthcare Costs Requires Less Talk And More Action
Tackling Rising Healthcare Costs Requires Less Talk And More Action Last October when we asked industry thought leaders, “What would be hot for 2016” (see our December 2015 issue), drug pricing was one topic consistently mentioned. Probably not much of a surprise considering the mass media’s fascination with portraying former Turing CEO Martin Shkreli as being everything that’s bad with biopharma. But the reality is that controversy over drug pricing has been around for as long as there...  Continue Reading...
Are You Ready To Go Beyond The Cutting Edge At BIO 2016?
Are You Ready To Go Beyond The Cutting Edge At BIO 2016? Being the 2015 educational planning committee co-chair for BIO provided behind the scenes insights into what makes for a good industry session proposal at BIO. But beyond that I also learned how important it is for those interested in putting together an educational session for a conference to begin the planning process early. So when Bayer’s VP and Head of the company’s east coast innovation center, Chandra Ramanathan, Ph.D., and I...  Continue Reading...
What Does The Successful Killing Of The Pfizer Allergan Deal Mean?
What Does The Successful Killing Of The Pfizer Allergan Deal Mean? When I wrote the opinion piece on the U.S. government’s successful killing of the planned Pfizer Allergan merger, it was on the heels of a March Editor’s Note on the current state of U.S. corporate taxes. There are those who argue that U.S. companies aren’t seeking to invert due to high U.S. tax rates. And while we can dispute the rationale behind why companies have been seeking to relocate outside the United States, what...  Continue Reading...
Evolving The Biopharma R&D Model — Improbable Players Are Changing The Game
Evolving The Biopharma R&D Model — Improbable Players Are Changing The Game At a recent conference* I overheard an executive comment that the clinical trial space remains one of the biggest bottlenecks to successful drug development. Sure, companies are developing much more sophisticated and targeted therapies. However, one of the problems this more individualized drug development creates is a slowdown in clinical trial recruitment. While new technologies are creating an enormous amount of clinical evidence, for the...  Continue Reading...